ANAVEX LIFE SCIENCES CORP. Shares Outstanding (Cover Page)
ANAVEX LIFE SCIENCES CORP. (AVXL) had Shares Outstanding (Cover Page) of 92.70 million shares as of 2026-08-28, per its 10-Q filed 2026-08-28.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-28
- 2026-08-28: Entity Common Stock, Shares Outstanding 92.70M shares.
- 2026-02-09: Entity Common Stock, Shares Outstanding 92.67M shares.
- 2025-11-24: Entity Common Stock, Shares Outstanding 89.35M shares.
- 2025-08-12: Entity Common Stock, Shares Outstanding 85.89M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-28 | 92.70M shares 10-Q · filed 2026-08-28 |
| 2026-02-09 | 92.67M shares 10-Q/A · filed 2026-08-28 |
| 2025-11-24 | 89.35M shares 10-K/A · filed 2026-08-28 |
| 2025-08-12 | 85.89M shares 10-Q · filed 2025-08-12 |
| 2025-05-13 | 85.37M shares 10-Q · filed 2025-05-13 |
| 2025-02-12 | 85.06M shares 10-Q · filed 2025-02-12 |
| 2024-12-23 | 84.82M shares 10-K · filed 2024-12-23 |
| 2024-08-06 | 84.80M shares 10-Q · filed 2024-08-06 |
| 2024-05-09 | 84.64M shares 10-Q · filed 2024-05-09 |
| 2024-02-07 | 82.11M shares 10-Q · filed 2024-02-07 |
| 2023-11-24 | 82.09M shares 10-K · filed 2023-11-27 |
| 2023-08-08 | 81.95M shares 10-Q · filed 2023-08-08 |
| 2023-05-08 | 80.84M shares 10-Q · filed 2023-05-09 |
| 2023-02-07 | 78.03M shares 10-Q · filed 2023-02-07 |
| 2022-11-28 | 77.96M shares 10-K · filed 2022-11-28 |
| 2022-08-09 | 77.94M shares 10-Q · filed 2022-08-09 |
| 2022-05-10 | 77.41M shares 10-Q · filed 2022-05-10 |
| 2022-02-08 | 76.17M shares 10-Q · filed 2022-02-09 |
| 2021-11-19 | 76.02M shares 10-K · filed 2021-11-24 |
| 2021-08-12 | 75.71M shares 10-Q · filed 2021-08-12 |
| 2021-05-11 | 70.04M shares 10-Q · filed 2021-05-13 |
| 2021-02-12 | 69.49M shares 10-Q · filed 2021-02-16 |
| 2020-12-28 | 66.96M shares 10-K · filed 2020-12-28 |
| 2020-08-06 | 60.19M shares 10-Q · filed 2020-08-06 |
| 2020-05-07 | 58.66M shares 10-Q · filed 2020-05-07 |
| 2020-02-06 | 58.66M shares 10-Q · filed 2020-02-06 |
| 2019-12-12 | 56.12M shares 10-K · filed 2019-12-16 |
| 2019-08-07 | 52.65M shares 10-Q · filed 2019-08-07 |
| 2019-05-08 | 49.12M shares 10-Q · filed 2019-05-09 |
| 2019-02-07 | 46.89M shares 10-Q · filed 2019-02-07 |
| 2018-12-12 | 46.59M shares 10-K · filed 2019-01-25 |
| 2018-08-09 | 45.43M shares 10-Q · filed 2018-08-09 |
| 2018-05-10 | 44.66M shares 10-Q · filed 2018-05-10 |
| 2018-02-07 | 44.57M shares 10-Q · filed 2018-02-07 |
| 2017-12-08 | 44.22M shares 10-K · filed 2017-12-11 |
| 2017-08-07 | 42.17M shares 10-Q · filed 2017-08-07 |
| 2017-05-10 | 41.38M shares 10-Q · filed 2017-05-10 |
| 2017-02-07 | 41.07M shares 10-Q · filed 2017-02-07 |
| 2016-12-12 | 39.61M shares 10-K · filed 2016-12-14 |
| 2016-08-11 | 35.71M shares 10-Q · filed 2016-08-11 |
| 2016-05-11 | 35.71M shares 10-Q · filed 2016-05-11 |
| 2016-02-05 | 34.65M shares 10-Q · filed 2016-02-08 |
| 2015-12-29 | 34.60M shares 10-K · filed 2015-12-29 |
| 2015-08-14 | 120.45M shares 10-Q · filed 2015-08-14 |
| 2015-05-14 | 77.24M shares 10-Q · filed 2015-05-14 |
| 2015-02-13 | 56.44M shares 10-Q · filed 2015-02-17 |
| 2014-12-15 | 54.68M shares 10-K · filed 2014-12-29 |
| 2014-08-12 | 38.26M shares 10-Q · filed 2014-08-13 |
| 2014-05-13 | 38.26M shares 10-Q/A · filed 2014-05-30 |
| 2014-02-14 | 37.64M shares 10-Q · filed 2014-02-14 |
| 2013-12-24 | 37.24M shares 10-K · filed 2013-12-30 |
| 2013-08-12 | 37.24M shares 10-Q · filed 2013-08-14 |
| 2013-05-17 | 30.24M shares 10-Q · filed 2013-05-17 |
| 2013-02-14 | 30.24M shares 10-Q · filed 2013-02-14 |
| 2012-12-28 | 30.24M shares 10-K · filed 2012-12-31 |
| 2012-08-17 | 30.24M shares 10-Q · filed 2012-08-17 |
| 2012-05-15 | 27.47M shares 10-Q · filed 2012-05-15 |
| 2012-02-14 | 27.47M shares 10-Q · filed 2012-02-14 |
| 2011-12-19 | 27.19M shares 10-K · filed 2011-12-22 |
| 2011-08-12 | 25.92M shares 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |